Skip to content

Development and Application of an Ultrasound Radiomics-Based Precision Diagnostic Model for Endometriosis-Associated Ovarian Cancer

Development and Application of an Ultrasound Radiomics-Based Precision Diagnostic Model for Endometriosis-Associated Ovarian Cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129088
Enrollment
Unknown
Registered
2026-07-30
Start date
2026-08-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian tumor

Interventions

Case group:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with adnexal masses who underwent surgery in our hospital from January 2017 to December 2025 and received a clear pathological diagnosis; 2. Completed transvaginal (or transrectal) and/or abdominal ultrasound within 30 days before surgery, with full static images available; 3. Lesions can be matched one-to-one with pathological results; 4. Cases belong to one of the following three categories: EAOC (including OCCC and EnOC), atypical endometriotic cysts with solid components suggested by preoperative ultrasound, or primary non-EAOC epithelial ovarian cancer.

Exclusion criteria

Exclusion criteria: 1. Received chemotherapy, radiotherapy, interventional therapy, or other treatments before surgery that significantly changed the lesion's imaging appearance; 2. Poor image quality, missing key slices, severe obstruction by rulers/text, or inability to outline the ROI; 3. Unclear pathological diagnosis or mixed pathology that can't be classified; 4. Recurrent tumors, metastatic tumors, or a history of previous pelvic malignancies that obviously interfere with this study's grouping.

Design outcomes

Secondary

MeasureTime frame
Area Under the Curve;Brier Score (BS);Positive likelihood ratio / Negative likelihood ratio / Diagnostic odds ratio;Calibration;Sensitivity/Specificity/Negative Predictive Value/Positive Predictive Value;

Countries

China

Contacts

Public ContactChen hui

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

ch11516@rjh.com.cn+86 18018676996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026